We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
AUM
$210M
AUM Growth
-$46.6M
Cap. Flow
-$51.2M
Cap. Flow %
-24.45%
Top 10 Hldgs %
27.94%
Holding
207
New
7
Increased
34
Reduced
78
Closed
27

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.32M
2
OPLN
Openlane
OPLN
+$2.29M
3
WBD icon
Warner Bros
WBD
+$1.84M
4
AAPL icon
Apple
AAPL
+$1.78M
5
PFE icon
Pfizer
PFE
+$1.71M

Sector Composition

Rank Sector Weight
1 Healthcare 16.89%
2 Technology 16.54%
3 Financials 8.8%
4 Consumer Discretionary 7.57%
5 Energy 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHLC icon
151
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
$162K 0.08%
+3,600
New +$157K
ECON icon
152
Columbia Emerging Markets Consumer ETF
ECON
$327M
$160K 0.08%
7,000
IMGN
153
DELISTED
Immunogen Inc
IMGN
$155K 0.07%
71,500
+12,000
+20% +$28.4K
DHR icon
154
Danaher
DHR
$135B
$143K 0.07%
1,128
NVDA icon
155
NVIDIA
NVDA
$5.01T
$131K 0.06%
32,000
FSTA icon
156
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.4B
$129K 0.06%
+3,717
New +$128K
OXY icon
157
Occidental Petroleum
OXY
$57B
$126K 0.06%
2,500
TT icon
158
Trane Technologies
TT
$106B
$114K 0.05%
900
WMB icon
159
Williams Companies
WMB
$90.5B
$112K 0.05%
4,000
DGRO icon
160
iShares Core Dividend Growth ETF
DGRO
$42.6B
$110K 0.05%
2,968
+783
+36% +$29.3K
BOND icon
161
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.28B
$107K 0.05%
1,000
CCXI
162
DELISTED
ChemoCentryx, Inc.
CCXI
$93K 0.04%
10,000
CELG
163
DELISTED
Celgene Corp
CELG
$83K 0.04%
900
-800
-47% -$76K
IBB icon
164
iShares Biotechnology ETF
IBB
$9.31B
$82K 0.04%
750
KO icon
165
Coca-Cola
KO
$354B
$78K 0.04%
1,520
ORLY icon
166
O'Reilly Automotive
ORLY
$72.4B
$74K 0.04%
3,000
-18,000
-86% -$456K
TCOM icon
167
Trip.com Group
TCOM
$27.5B
$74K 0.04%
2,000
LIVN icon
168
LivaNova
LIVN
$4.3B
$72K 0.03%
1,000
BFH icon
169
Bread Financial
BFH
$4.21B
$70K 0.03%
627
CVX icon
170
Chevron
CVX
$388B
$62K 0.03%
500
JAZZ icon
171
Jazz Pharmaceuticals
JAZZ
$15.9B
$57K 0.03%
400
-500
-56% -$67.2K
FOMX
172
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$48K 0.02%
20,000
+9,300
+87% +$27.8K
OVV icon
173
Ovintiv
OVV
$17.5B
$33K 0.02%
1,282
-695
-35% -$21.7K
XLE icon
174
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$32K 0.02%
1,000
MMP
175
DELISTED
Magellan Midstream Partners, L.P.
MMP
$24K 0.01%
378

Similar funds

Grace Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Grace Capital held 207 positions worth $210M, down 18% from $256M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grace Capital withdrew a net $51.2M in Q2 2019, closing 27 positions and reducing 78 holdings. Its most notable exit was Norfolk Southern, an estimated $1.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Grace Capital opened a new position in IAA, Inc. Common Stock worth $981K.

  • Grace Capital's largest Q2 2019 buy was IAA, Inc. Common Stock: 25,307 shares worth $981K.
  • Grace Capital added most to MyoKardia, Inc. Common Stock in Q2 2019, an estimated $3.43M increase.
  • Grace Capital's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.32M.
  • Grace Capital fully exited Norfolk Southern in Q2 2019, selling an estimated $1.18M.
  • Grace Capital's ten largest holdings make up 28% of its $210M portfolio in Q2 2019.
  • Grace Capital opened 7 new positions and closed 27 in Q2 2019.
  • Grace Capital's portfolio value fell 18% quarter-over-quarter to $210M.

Based on Grace Capital's 13F filing for Q2 2019, filed 14 Aug 2019.